Clinical Trials Browser

Phase 3 × Completed × selinexor × Clear all

NCT03110562 2024-08-21

BOSTON

Phase 3 Completed

402 enrolled 22 charts 2 FDA

Multiple Myeloma, Recurrence

NCT04534725 2023-08-24

C-SMART

Phase 3 Completed

COVID-19, Neoplasms